FDA Gives 510(k) Clearance to bioMérieux’s Mass Spectrometry ID System
The MALDI-TOF mass spectrometry identification system is now commercially available in countries that recognize CE-marking and in the U.S.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Mass Spectrometry Reagents & Test Kits |
The MALDI-TOF mass spectrometry identification system is now commercially available in countries that recognize CE-marking and in the U.S.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Colorectal |
A new systematic review of colorectal cancer explored predictors of screening adherence among average risk adults across three decades.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Cancer |
Deaths from cancer are expected to increase over the next decade due to screening deficits resulting from COVID-19 pandemic.
Read MorePosted by Andy Lundin | Mar 18, 2022 | Uncategorized |
Researchers discovered a set of biomarkers in blood plasma that could lead to improved diagnostic tests for Alzheimer’s disease.
Read MorePosted by Andy Lundin | Mar 18, 2022 | Covid 19 |
Researchers have developed a PCR test that uses molecular beacons to diagnose a COVID-19 infection and the variant causing the infection.
Read More